Fig. 1From: The prognostic value and immune correlation of IL18 expression and promoter methylation in renal cell carcinomaIL18 is highly expressed and associated with poor prognosis in RCC patients. A. Relative mRNA expression of IL18 between tumor and adjacent normal tissues using the data from TCGA cohort; B Relative expression of IL18 between tumor and adjacent normal tissues using the data from CPTAC cohort; C–F The expression of IL18 expression in different stages and pathological grades of patients from TCGA cohort; G, H Kaplan–Meier survival analysis of IL18 expression for overall survival and disease-free survival of patients from TCGA RCC cohort, respectivelyBack to article page